A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortés J, Gomez HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Murillo SM, Park YH, Sohn JH, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin E, Grinsted L, Schiavon G, Foxley A, Rugo HS

Publication

Future oncology (London, England)

Publication ID (Profile URL)

https://researcherprofiles.org/profile/557137719

Publication Year

2024

PubMed ID

39283299

Publication Title

Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortés J, Gomez HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Murillo SM, Park YH, Sohn JH, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin E, Grinsted L, Schiavon G, Foxley A, Rugo HS. A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer. Future Oncol. 2024; 20(37):2901-2913.